MedTrace Logo

The Effect of Acute Transcranial Bright Light on Anxiety Symptoms

NCT01938937 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-02-26

No results posted yet for this study

Summary

The purpose of this study is to determine if transcranially administered bright light has acute effect on anxiety symptoms.

Conditions

Interventions

DEVICE

Transcranial bright light device

DEVICE

Transcranial sham device

Sponsors & Collaborators

  • Valkee Oy

    collaborator INDUSTRY

  • University of Oulu

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01938937 on ClinicalTrials.gov